Kurz gefasst
Fachartikel in der Zeitschrift CHEST, 2024. Verfasst von Adelina Yafasova und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. Electronic address: adelinay@hotmail.com. Hauptthemen laut MEDLINE: Venous Thromboembolism, Sarcoidosis, Registries. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Chronic inflammation is increasingly recognized as a risk factor for VTE, but unlike other inflammatory diseases including systemic lupus erythematosus and rheumatoid arthritis, data on the risk of VTE in patients with sarcoidosis are sparse. RESEARCH QUESTION: Do patients with sarcoidosis have a higher long-term risk of VTE (pulmonary embolism or DVT, and each of these individually) compared with the background population? STUDY DESIGN AND METHODS: Using Danish nationwide registries, patients aged ≥ 18 years with newly diagnosed sarcoidosis (two or more inpatient/outpatient visits, 1996-2020) without prior VTE were matched 1:4 by age, sex, and comorbidities with individuals from the background population. The primary outcome was VTE. RESULTS: We included 14,742 patients with sarcoidosis and 58,968 matched individuals (median age, 44.7 years; 57.2% male). The median follow-up was 8.8 years. Absolute 10-year risks of outcomes for patients with sarcoidosis vs the background population were the following: VTE, 2.9% vs 1.6% (P < .0001), pulmonary embolism, 1.5% vs 0.7% (P < .0001), and DVT, 1.6% vs 1.0% (P < .0001), respectively. In multivariable Cox regression, sarcoidosis was associated with an increased rate of all outcomes in the first year after diagnosis (VTE: hazard ratio [HR], 4.94; 95% CI, 3.61-6.75) and after the first year (VTE: HR, 1.65; 95% CI, 1.45-1.87) compared with the background population. These associations persisted when excluding patients with a history of cancer and censoring patients with incident cancer during follow-up. Three-month mortality was not significantly different between patients with VTE with and without sarcoidosis (adjusted HR, 0.84; 95% CI, 0.61-1.15). INTERPRETATION: In this nationwide cohort study, sarcoidosis was associated with a higher long-term risk of VTE compared with a matched background population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. Electronic address: adelinay@hotmail.com.
- Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
- Department of Rheumatology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
- Department of Cardiology, Herlev and Gentofte University Hospital, Herlev, Denmark.
- Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Cardiology, Zealand University Hospital, Roskilde, Denmark.
Zitieren
APA
Yafasova, A., Fosbøl, E. L., Gustafsson, F., Krintel, S. B., Kristensen, S. L., Schou, M., Petersen, J. K., Sun, G., Rossing, K., Doi, S. N., Køber, L., & Butt, J. H. (2024). Long-Term Risk of VTE in Sarcoidosis. CHEST. https://doi.org/10.1016/j.chest.2024.01.042
Vancouver
Yafasova A, Fosbøl EL, Gustafsson F, Krintel SB, Kristensen SL, Schou M, et al. Long-Term Risk of VTE in Sarcoidosis. CHEST. 2024. doi:10.1016/j.chest.2024.01.042
BibTeX
@article{Yafasova2024,
author = {Yafasova, Adelina and Fosbøl, Emil L and Gustafsson, Finn and Krintel, Sophine B and Kristensen, Søren L and Schou, Morten and Petersen, Jeppe K and Sun, Guoli and Rossing, Kasper and Doi, Seiko N and Køber, Lars and Butt, Jawad H},
title = {Long-Term Risk of VTE in Sarcoidosis},
journal = {CHEST},
year = {2024},
doi = {10.1016/j.chest.2024.01.042}
}
EUVIMED